Latest News - Research and Publications

Thursday, January 17, 2019

RealSelf Survey: 36 Percent of US Adults Are Considering Cosmetic Treatments

More than four in five U.S. adults want to improve their personal well-being or appearance in 2019, and 36 percent are considering cosmetic treatments, according to new RealSelf survey. Fully 82 pe…

Read the full story

Wednesday, January 16, 2019

Dermatologists Prescribe the Most Antibiotics, But Usage Is Changing

The use of antibiotics to treat inflammatory skin conditions like acne and rosacea is decreasing over time, but there has been an increase in prescriptions associated with dermatologic surgical proced…

Read the full story

Tuesday, January 15, 2019

New Review Highlights Comprehensive Treatment Guidelines for Severe AD

A team of investigators from the University of Colorado College of Nursing at CU Anschutz Medical Campus and National Jewish Health has identified comprehensive guidelines for managing severe atopic d…

Read the full story

Tuesday, January 15, 2019

Study: States with Fewer Melanoma Diagnoses Have Higher Death Rates

States with fewer melanoma diagnoses actually have higher death rates, report researchers at University of Utah Health. The researchers conducted a state-by-state analysis to understand the geograp…

Read the full story

Friday, January 04, 2019

“Christmas Berry” Plant Compound Could Fight Uveal Melanoma

A compound extracted from the Christmas berry primrose plant may stops the growth of uveal melanoma, according to  preliminary tests. With further testing, the discovery could lead to new ther…

Read the full story

Thursday, January 03, 2019

JAK Kinase Inhibitors Show Promise in Treating Alopecia

UPDATED -- New research suggests selective oral JAK kinase inhibitors may play a role in treating moderate-to-severe alopecia areata (AA).  The findings were presented at the Inflammatory Skin Di…

Read the full story

Wednesday, December 19, 2018

National Rosacea Society: New Grants Available in 2019

The National Rosacea Society (NRS) has new grants available in 2019 to support research into potential causes and other key aspects of rosacea that may lead to improvements in its management, preventi…

Read the full story

Tuesday, December 18, 2018

Rio Professor Develops Sunscreen for Hair

A Rio professor and her team of students have developed the first national product capable of protecting hair from sun radiation. According to Ana Percebom, of the Scientific Technical Center of Un…

Read the full story

Tuesday, December 18, 2018

New Study Seeks to Improve Skin Cancer Prevention in Young Adults Via a New Website

Researchers out of Rutgers Cancer Institute of New Jersey and colleagues from across the country are conducting a study to evaluate the reach and effectiveness of an online program targeted at skin ca…

Read the full story

Thursday, December 13, 2018

New Study Investigates Prurigo Nodularis Treatments

Emerging treatments such as neurokinin-1 receptor antagonists show the most promise for prurigo nodularis, according to a review in JAMA Dermatology. Neurokinin-1 receptor is a target of substance …

Read the full story

Wednesday, December 12, 2018

AD, Suicidal Thoughts and Attempts Linked

Patients with eczema may be more likely to have suicidal thoughts and attempts compared to their counterparts without eczema, according to a new study in JAMA Dermatology. Researchers evaluated the…

Read the full story

Tuesday, December 11, 2018

Case Study: Whole Body Cryotherapy Causes Cold Burn Injury

A 71-year-old man experienced a blistering cold burn after receiving a whole-body cryotherapy treatment for back pain and arthritis, according to a case study published online in JAAD Case Reports. …

Read the full story

Tuesday, December 11, 2018

Dermatologists Need More Info About Cannabinoids

Dermatologists are interested in learning more about cannabinoids and recommending them to patients, according to a new survey in Journal of Drugs in Dermatology. However, many are concerned a…

Read the full story

Monday, December 10, 2018

Asana Biosciences Gets Fast Track Designation from FDA for Dual JAK/SYK Inhibitor for AD

The FDA has granted Fast Track designation to Asana BioSciences’ investigational oral Janus Kinase (JAK) and Spleen Tyrosine Kinase (SYK) dual inhibitor ASN002 for the treatment of moderate-to-s…

Read the full story

Friday, December 07, 2018

Naked Eye, Smart Phone Apps May Miss Melanomas

The naked eye alone is not enough to accurately diagnosis skin cancer and smart phone apps may also miss melanomas, according to a new review published in The Cochrane Library as part of a Special Col…

Read the full story
Load More